Taken together, these results do not appear to argue in favour of overwhelming diuretic effects with SGLT2 inhibition as the primary mechanism responsible for improvements in HF outcomes, but rather potential improvements in cardiac function and maintenance of kidney function that ultimately improve sodium balance and volume status. This evidence concerns the gene SLC5A2 and hydrops fetalis.